Antimicrobial Resistance Diagnostic Initiative

  29 June 2024

The WHO Antimicrobial Resistance (AMR) Diagnostic Initiative aims to enhance diagnostic capacity globally, supporting countries in improving microbiology laboratory capacity and providing quality testing for bacterial, fungal, and resistant pathogens. The initiative includes a strategic framework, assessment tools, a Global AMR Laboratory Network, and research to improve diagnostic tools’ precision, speed, and usability for patient management, infection prevention, control measures, outbreak investigations, and routine AMR surveillance.

Further reading: WHO
Author(s): WHO
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed